In contrast, experiments combining pharmacological stimulation and gene silencing, demonstrate an inhibitory effect of FFAR4 on migration of melanoma and prostate cancer cells, and on proliferation of the latter [46,56], while indirect evidences suggest similar inhibitory effects on lung and breast cancer cells [47,57]. Here, FFAR4 is linked to breast cancer.